Text this: Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

 _    _    __   __               ___       _____  
| || | ||  \ \\/ //     ___     / _ \\    / ___// 
| || | ||   \ ` //     /   ||  | / \ ||   \___ \\ 
| \\_/ ||    | ||     | [] ||  | \_/ ||   /    // 
 \____//     |_||      \__ ||   \___//   /____//  
  `---`      `-`'       -|_||   `---`   `-----`   
                         `-`